Deborah Doroshow, MD, on the Disappointments Uncovered About Inpatient Immunotherapy
Deborah Doroshow, MD, PhD, discusses a study finding that cancer patients receiving care as inpatients who start on in-patient immune checkpoint inhibitors (ICI) generally do not live long enough to benefit from the drugs.
Mount Sinai Study May Help Cancer Patients Keep Their Bladder
Feb 19, 2026 View All Press Releases
Mount Sinai Showcases Hematology Research at the 67th ASH Annual Meeting
Dec 03, 2025 View All Press Releases
Mount Sinai Researchers Discover New Way Cells Control RNA Production
Apr 21, 2025 View All Press Releases
Mount Sinai Researchers Uncover Why Some Leukemia Cells May Resist Treatment
Oct 30, 2024 View All Press Releases
Mount Sinai Researchers Publish Critical Examination of New Brain Tumor Drug
Sep 23, 2024 View All Press ReleasesMount Sinai’s Staten Island Cancer Center Moves to New Site
Nov 09, 2023 View All Press Releases
Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race
Sep 29, 2023 View All Press Releases